Sort
39,280 grants matching “leukemia”
Immunity to MHC-restricted phosphopeptides in healthy donors and cancer patients
$336,853Victor H. Engelhard · University Of Virginia · R01 · FY2016 · CA
Immunity to MHC-restricted phosphopeptides in healthy donors and cancer patients
$336,853Victor H. Engelhard · University Of Virginia · R01 · FY2015 · CA
Posttranscriptional Regulation of Oncogene Messenger RNA
$336,849Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2002 · CA
Survival Mechanisms in Leukemic NK Cells
$336,849Thomas P Loughran · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2009 · CA
In vivo MR Evaluation of Cell Therapy for Stroke
$336,843Quan Jiang · Henry Ford Health System · R01 · FY2009 · NS
HSV Amplicon Activation of Innate and Adaptive Immunity
$336,837University Of Miami School Of Medicine · R01 · FY2004 · CA
Development of new therapeutic approaches for endometrial cancer
$336,835Suryavathi Viswanadhapalli · University Of Texas Hlth Science Center · R01 · FY2024 · CA
T-cell Transformation by Oncoviruses
$336,785Genoveffa Franchini · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Core A - Clinical Database.
$336,776Peter Westervelt · Washington University · P01 · FY2020 · CA
SOUTHWEST ONCOLOGY GROUP--OPERATIONS OFFICER
$336,755Cancer Therapy And Research Center · U10 · FY2002 · CA
The role of glutaminolysis as a therapeutic target in T-ALL
$336,720Daniel Herranz · Rbhs -Cancer Institute Of New Jersey · R01 · FY2019 · CA
Combining hu14.18-IL2 and NK cell infusions to treat neuroblastoma
$336,665Christian Capitini · University Of Wisconsin-Madison · R01 · FY2019 · CA
Mechanisms of Leukemogenesis in Down Syndrome
$336,656John D Crispino · Northwestern University At Chicago · R01 · FY2017 · CA
How HTLV-I Tax and HBZ control telomerase activity to induce adult T-cell leukemia
$336,641Christophe P Nicot · University Of Kansas Medical Center · R01 · FY2019 · CA
Transcription cycle regulation by nutrients
$336,600Nuria Morral · Indiana University Indianapolis · R01 · FY2024 · DK
KIR Genotyping Core
$336,578Elizabeth A Trachtenberg · University Of Minnesota · P01 · FY2012 · CA
CAML in T cell Development and Function
$336,575Richard J Bram · Mayo Clinic Rochester · R01 · FY2010 · AI
Dynamics of Non-equalibrium Cell State Transitions in Cell Populations
$336,562Sui Huang · Institute For Systems Biology · R01 · FY2017 · GM
How HTLV-I Tax and HBZ control telomerase activity to induce adult T-cell leukemia
$336,555Christophe P Nicot · University Of Kansas Medical Center · R01 · FY2016 · CA
Role of miR155 in Leukemogenesis
$336,489Carlo M Croce · Ohio State University · R01 · FY2010 · CA
NOVEL RETINOIDS FOR LEUKEMIA THERAPY
$336,441University Of Alabama At Birmingham · R01 · FY2000 · CA
Efficient Assemblage of Complex Biologically-Active Targets Using Donor-Acceptor
$336,418Keith Thomas Mead · Mississippi State University · R15 · FY2012 · GM
Combined inhibition of CXCR4 and FLT3-ITD signaling in acute myeloid leukemia
$336,397Michael W Andreeff · University Of Tx Md Anderson Can Ctr · R21 · FY2010 · CA
Chelation strategies for s-, p-, and f-block radionuclides for targeted alpha therapy
$336,382Justin J Wilson · Cornell University · R01 · FY2022 · EB
Training Program in Molecular Hematology
$336,349William H Fleming · Oregon Health & Science University · T32 · FY2007 · HL